Fish oil improves hemodynamic stabilization and inflammation after resuscitation in a rat model of hemorrhagic shock
© Li et al; licensee BioMed Central Ltd. 2012
Received: 7 November 2011
Accepted: 10 January 2012
Published: 10 January 2012
Hemorrhagic shock followed by resuscitation stimulates an inflammatory response. This study tests the hypothesis that treatment with fish oil will attenuate inflammatory responses and stabilize hemodynamics.
Male SD rats (n = 48; 250~300 g) were randomly divided into 4 groups: SHAM, hemorrhagic shock (HS), hemorrhagic shock/resuscitation (HS/R) and fish oil (FO). Shock was induced, and a mean arterial pressure (MAP) was maintained at 35 to 40 mmHg for 60 minutes. Resuscitation was carried out by returning half of the shed blood and Ringer's lactate solution to the animal. In FO group, fish oil (0.2 g/Kg) was infused through caudal vena at 30 minutes after shock. Half of each group was killed at 30 minutes and at 4 hours after resuscitation. Then several kinds of inflammation and oxidative stress indicators such as IL-6, MPO and GSH were tested.
FO group required less resuscitative fluid and had higher urinary output at the recovery periods from hemorrhagic shock than HS/R group(p < 0.001). After resuscitation, the MAP of HS/R group markedly declined than FO group (p < 0.001). The inflammatory indexes of FO group were lower than HS group and HS/R group and the same as sham group. But the level of endotoxin in FO group was significantly higher than sham group at 4 hours.
Fish oil pretreatment before fluid resuscitation showed a beneficial effect to the hemodynamic stabilization and inflammation reduction in HS/R rat model.
Hemorrhagic shock (HS) remains a major cause of death in both civilian and combat traumatic injury. It followed by resuscitation is considered as an insult frequently induces a systemic inflammatory response syndrome (SIRS) that results in multiple-organ dysfunction syndrome (MODS), which is a major clinical problem. HS represents the acute hypovolemia and hemodynamic derangement and the mechanism is recognized to be the increasing of reactive oxygen species generation, and endothelial activation after supplementation with ambient oxygen in a prior ischemic field, and inducing many systemic inflammatory factor released[3–5].
Fish oil as pharmacological nutrients could directly and indirectly decreasing the production of inflammatory eicosanoids, cytokines, and reactive oxygen species and the expression of adhesion molecules. Pscheidl EM et al and Pscheidl E et al have shown that fish oil not only attenuates inflammatory reactions, but ameliorates host defense and even improves splanchnic blood flow. Anti-inflammatory properties and benefit in splanchnic blood flow by fish oil could be protective for these tissue in ischemia/re-perfusion (I/R) [9, 10]. Accordingly, this maybe a new approach to alleviate inflammation and hemodynamic stabilization in HS treatment. However, almost researches were focused on the pre-feeding of fish oil and few articles were after HS treatment.
So, our hypothesis was that infusion of fish oil before resuscitation in hemorrhagic shock rats, would help to minimize the post-resuscitation inflammatory responses and to stabilize hemodynamics.
Animals and methods
Rat model of Hemorrhagic Shock and Resuscitation
Forty-eight male SD rats of a mean(± SD) weight of 269.26 ± 12.68 g were used. Animals were provided by Medical Experiment Animal Center of Jinling Hospital(Nanjing, China). Temperature range between at 25°C-28°C with a 12:12-h light-dark cycle. Rats were allowed free access to water and chow. The protocol were approved by the institutional animal care committee.
HS/R model: All rats were anesthetized with 60 mg/kg ketamine intramuscular injection and placed on a temperature-controlled heating pads, which was heated while shock was induced and temperature was sustained 37°C. The left femoral artery and femoral vein were exposed and cannulated through a short incision. Heparin (200 U/kg) was infused immediately through femoral vein following cannulation. The artery catheter was connected to a multi-channel recorder (Electronics for Medicine, TX) for the monitoring of systolic, diastolic, and mean arterial pressures (MAP) per 3 minutes, heart rate(HR) was also measured. The target MAP(35 ~ 40 mm Hg) was induced by removing blood slowly through the femoral vein cannula during a total time of 15 minutes and maintained at 35 to 40 mm Hg for 60 minutes. The animals in shock group were induced without resuscitation and killed at the end of shock instantly. At the point of 75 minute, resuscitation which would take 30 minutes and begin by returning half of the shed blood to the animal at the speed of 0.5 mL/min and giving Ringer's solution was carried out in HSR group and FO group. And Infusion was withheld if MAP exceeded 90% of baseline and re-started if declined. The rats in FO group were injected by fish oil (0.2 g/Kg) through the caudal vena at 45th minute. The rats in sham group were cannulated without inducing of shock and kept anesthetized for a same length of time with other groups'. At the end of 30 minutes of resuscitation, half of the animals of these three groups were randomly sacrificed to collect blood samples, and the others were killed at the end of 4 hours. The 2-3 ml sample was centrifuged at 4°C. After centrifugation, serum was kept refrigerated at -80°C until assayed. The volumes of fluid given and urine produced by the end of resuscitation period were recorded.
All animals were killed while anesthetized using aortic transaction.
MDA MPO and GSH assays
To carry out the assays, the serum was assayed spectrophotometrically for malondialdehyde (MAD), myeloperoxidase(MPO) activity and reduced glutathione(GSH) level with assay kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). All procedures were done in accordance with the manufacturer's instructions.
Measurement of IL-6, TNF-α, Endotoxin by enzyme-linked immunosorbent assay
The blood sample was centrifuged at 10 000 xg for 15 min at 4°C. The supernatant was assayed for interleukin (IL)-6, Tumor necrosis factor α (TNF-α), Endotoxin levels by enzyme-linked immunosorbent assay kits (R&D Systems, Minneapolis, MN, USA) in accordance with the manufacturer's instructions. The absorbance at 450 nm was determined using a micro-plate reader (Tecan's, Sunrise, Unterberg strasse IA, Austria).
MAP, concentrations of oxidative and pro-inflammatory mediators were expressed by their mean ± SD. Comparisons of various oxidative and inflammatory molecules, blood, and additional fluids volumes and MAP between the 4 groups were performed by ANOVA test. p < 0.05 was considered statistically significant.
Volume of blood loss, resuscitation fluids and urine
Volumes of Blood Withdrawn of the Induction and Maintenance of Shock, Fluids Given, and Urines During Resuscitation(Median ± SE)
Volume loss for induction to shock
(mL/kg of body weight)
9.97 ± 0.22
10.19 ± 0.92
10.23 ± 0.45
Volume loss for maintenance of shock
(mL/kg of body weight)
11.53 ± 0.46
11.57 ± 1.13
12.43 ± 0.84
Ringer's solution (mL)
4.80 ± 0.59
4.05 ± 0.89
0.93 ± 0.11
0.14 ± 0.22*
0.65 ± 0.19*
0.87 ± 0.21
Mean arterial pressure (MAP)
After resuscitation, the MAP of sham group, resuscitation group and FO group in four different time points
4 Hours Post-resuscitation
121.75 ± 8.54
109.00 ± 2.16
109.8 ± 2.17
122.25 ± 6.08*
76.5 ± 2.08*
96 ± 7.07
116.25 ± 4.86*
72.5 ± 2.88*
91.10 ± 1.41
123.00 ± 7.12*
63.75 ± 0.957*
87.05 ± 3.40
Oxidative and Inflammatory Molecules
At 30 minutes post-resuscitation, the serum TNF-α was markedly elevated in HS, HS/R and FO groups but not in the sham group. The serum IL-6 and endotoxin was significantly increased in HS and HS/R groups when compared with sham group. Pretreatment with fish oil significantly decreased the serum IL-6 and Endotoxin levels in FO group when compared with the HS and HS/R groups.
Mean Concentrations ± SE of the of Various Oxidative and Inflammatory Molecules
30 Minutes Post-resuscitation
4 Hours Post-resuscitation
59.53 ± 15.02
197.59 ± 18.33*
222.02 ± 13.21*
243.0 ± 10.2*
42.00 ± 1.08
197.59 ± 18.33* #
66.07 ± 9.03
43.31 ± 0.084
21.71 ± 0.78
84.80 ± 5.66* #
122.01 ± 24.72* #
22.26 ± 2.35
22.80 ± 1.06
84.80 ± 5.66*
122.85 ± 31.23* #
54.89 ± 5.22
0.22 ± 0.009
0.87 ± 0.056* #
1.26 ± 0.116* #
0.24 ± 0.016
0.29 ± 0.046
0.87 ± 0.056* #
3.60 ± 0.358* #
2.58 ± 0.24*
Total GSH (μmol/L)
703.75 ± 9.64
741.10 ± 31.76
714.96 ± 23.40
719.47 ± 13.0
680.77 ± 31.9
741.1 ± 31.77
719.47 ± 16.65
717.1 ± 16.89
273.71 ± 15.4
259.00 ± 5.83
255.91 ± 3.87
262.84 ± 21.2
283.31 ± 8.02
259.00 ± 5.83
254.33 ± 8.14
269.42 ± 3.48
0.78 ± 0.047
0.70 ± 0.033
0.72 ± 0.013
0.73 ± 0.06
0.81 ± 0.073
0.70 ± 0.033
0.70 ± 0.033
0.75 ± 0.060
15.72 ± 11.59
43.91 ± 1.96* #
52.55 ± 5.22* #
27.78 ± 4.54*
12.32 ± 5.16
43.91 ± 1.96* #
59.67 ± 12.87* #
17.55 ± 5.14
26.55 ± 3.61
199.11 ± 18.06* #
257.74 ± 12.18* #
172.5 ± 58.3*
27.50 ± 8.08
199.11 ± 18.06* #
356.93 ± 9.21* #
61.95 ± 6.26
The levels of total GSH, reduced GSH and reduced/total GSH had no difference at the two time points in the four groups. The MDA levels, as a major degradation product of lipid per-oxidation, were found to be significantly higher in HS, HS/R and FO groups as compared with those of the sham group at 30 min post-resuscitation, while treatment with FO abolished these elevations at 4 hours. MPO, a marker of neutrophils, had the same tendency as MDA.
Hemorrhagic shock is considered as an insult frequently leading to systemic inflammatory response syndrome including the systemic release of pro-inflammatory cytokines. And an increase in systemic pro-inflammatory cytokines was associated with cellular injury and remote organ dysfunction[12–14]. On this concept, the routine clinical medical treatment should minimize excessive inflammatory reaction induced by ischemia/re-perfusion. Many animal studies published so far, have shown the advantage of fish oil on ischemia/re-perfusion and hemorrhagic shock/resuscitation through alleviating the inflammatory response and organ protection. Similarly, several clinical studies have confirmed that fish oil may decrease inflammatory cytokine release in several diseases and improves splanchnic blood flow[7, 8]. However, the benefits of clinical use of fish oil in HS/R patients remains unclear, which in part prompted the present study.
The present study found that during shock induction the blood volume withdrawn were same in every group. And the volume in FO group at shock maintenance was slightly more than the other groups', although without statistically significant(Table 1). The probable reason is that the infusion of fish oil increased volume loss for maintenance of shock in FO group.
The use of fish oil was associated with hemodynamic stability. In fact, the FO group required less resuscitation fluid than HS/R group, and had higher urinary output at the recovery from hemorrhagic shock than HS and HS/R groups (Table 1). In Figure 1, we could find that there was no difference in MAP among the groups at the end of resuscitation, but after that the MAP of HS/R group and FO group both dropped without intervention. So the four time points were selected to analyze the MAP in each group (Table 2). Except the 105th min, at other three time points, the MAPs in FO group were higher than HS/R group's. Meanwhile, the MAP of HS/R group was dramatically decreased and significantly less than the MAP in the previous time points. It may be argued that it merely was the extra infusion of fish oil improved the MAP in FO group. There are three reasons advocating that not the infusion of itself, but the pharmacological effects of fish oil worked. Firstly, during the infusion of fish oil, the MAP was maintained by withdrawing and infusion blood through femoral vein and the loss volumes during shock have no significantly difference between HS/R group and FO group. Secondly, at the end of resuscitation each group has the same MAP. Thirdly, the intravenous supply of fish oil can lead to a change in membrane FA patterns after a short time(3-5 hours)[16, 17], exerts anti-inflammatory and alters spectrum of metabolites in the situation of inflammatory stimulation. Moreover, the bolus administration of FO solution in rats achieves incorporation of n-3 PUFAs into cell membranes after only 60 min . So, these three causes provide a credence to the aspect that the pharmacological effects rather than the infusion itself ameliorated the MAP.
Additionally, at 30 minutes post-resuscitation, the levels of IL-6, MDA and MPO in FO group were significantly lower than HS group's and HS/R group's, but this difference was not found in TNF-α. At 4 hours post-resuscitation, the levels of TNF-α, MDA and MPO in FO group were dramatically lower than those in HS group, and the levels of IL-6, MDA and MPO were lower than HS/R group's. The "classic" explanation for the effects of fish oil on regulation of inflammatory host responses is that the administration of fish oil inhibits the production of pro-inflammatory cytokines, such as TNF-α, IL-1β and IL-6, and seems to positively modulate the production of the anti-inflammatory cytokine IL-10[19, 20]. Ertel et al pre-fed mice with fish oil for 3 weeks, subjected them to HS/R, and harvested peritoneal macrophages at 24 hours post-resuscitation. They found that fish oil prevented an increase in levels of circulating prostaglandin E2 (PGE2) release seen in mice fed with corn oil or safflower oil.
In this study, we observed that the concentration of endotoxin in FO group was significantly lower than shock group and HS/R groups. The reason should be that intestinal ischemia/reperfusion results in damage to the intestinal mucosa, with loss of barrier function for endogenous bacteria. This means that bacteria and toxins from the intestine can be translocated into the bloodstream and other organs. But the administration of fish oil promoted intestinal blood flow in the rats and thus possibly prevented the destruction of intestinal barrier function associated with ischemia/reperfusion. A study with endotoxemia rats confirmed the positive effects of fish oil infusion on the microcirculation in the splanchnic area, and the number of viable bacteria in the liver and small bowel lymph node were significantly reduced.
At the same time, we found that the concentration of endotoxin in FO group at 4 hours point was dramatically higher than sham group, however there is no difference in oxidative stress and Inflammatory indexes between them. Why the rats in FO group have slightly pathological changing with obvious endotoxemia? This phenomenon might ascribe to the blunting of the response to endotoxin and reducing of inflammatory release. Pittet. YK et al have proved that 0.2 g/Kg perfusion of fish oil immediately (2 hours before endotoxemia) can blunted the response to endotoxin in healthy subjects after 3 hours. Once fish oil administrated, the fatty acids it contained would incorporate into cell membrane phospholipids and play key roles in physicochemical and functional characteristics of the cell membranes. It can modify macrophage membranes and reduce its phagocytosis and adhesion function, and decreases the mortality and severity of SIRS. Mayer et al. have shown that several hours of parenteral nutrition with fish oil significantly decreases the ω-6/ω-3 FA ratio in the plasma-free FA fraction and in the monocyte membrane lipid pool which was associated with a suppression of monocyte generation of pro-inflammatory cytokines (TNF-α, Interleukin-1, -6, -8) in response to endotoxin. Oz et al showed that 6 days of a fish oil diet could protect rats from the hepatic damage associated with lipopolysaccharide (LPS) administration.
In this study, the HS rats were resuscitated with half of the shed blood and Ringer's solution and administered fish oil before resuscitation in order to ensure the model simulates clinical practicing. The results from the present study support our hypothesis that treatment with fish oil can alter the inflammatory response to HS/R, blunt the response to endotoxin and improve the hemodynamic stabilization after resuscitation.
Our study firstly demonstrates that infusion of fish oil before resuscitation not only can alter the inflammatory response to HS/R but also blunt the response to endotoxin. Finally, the alleviation of inflammatory response and endotoxemia results in hemodynamic stabilization.
- Alam HB, Rhee P: New developments in fluid resuscitation. Surg Clin North Am. 2007, 87 (1): 55-72. vi, 10.1016/j.suc.2006.09.015View ArticlePubMedGoogle Scholar
- Jarrar D, Chaudry IH, Wang P: Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches (Review). Int J Mol Med. 1999, 4 (6): 575-583.PubMedGoogle Scholar
- Baue AE: Multiple organ failure, multiple organ dysfunction syndrome, and the systemic inflammatory response syndrome-where do we stand?. Shock. 1994, 2 (6): 385-397. 10.1097/00024382-199412000-00001View ArticlePubMedGoogle Scholar
- Deitch EA: Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg. 1992, 216 (2): 117-134. 10.1097/00000658-199208000-00002PubMed CentralView ArticlePubMedGoogle Scholar
- Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB, Ward PA: Ischemia/reperfusion injury. J Surg Res. 2002, 105 (2): 248-258. 10.1006/jsre.2002.6385View ArticlePubMedGoogle Scholar
- Calder PC: n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006, 83 (6 Suppl): 1505S-1519S.PubMedGoogle Scholar
- Pscheidl EM, Wan JM, Blackburn GL, Bistrian BR, Istfan NW: Influence of omega-3 fatty acids on splanchnic blood flow and lactate metabolism in an endotoxemic rat model. Metabolism. 1992, 41 (7): 698-705. 10.1016/0026-0495(92)90307-VView ArticlePubMedGoogle Scholar
- Pscheidl E, Schywalsky M, Tschaikowsky K, Boke-Prols T: Fish oil-supplemented parenteral diets normalize splanchnic blood flow and improve killing of translocated bacteria in a low-dose endotoxin rat model. Crit Care Med. 2000, 28 (5): 1489-1496. 10.1097/00003246-200005000-00039View ArticlePubMedGoogle Scholar
- Peltier S, Malaisse WJ, Portois L, Demaison L, Novel-Chate V, Chardigny JM, Sebedio JL, Carpentier YA, Leverve XM: Acute in vivo administration of a fish oil-containing emulsion improves post-ischemic cardiac function in n-3-depleted rats. Int J Mol Med. 2006, 18 (4): 741-749.PubMedGoogle Scholar
- Hassan IR, Gronert K: Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. J Immunol. 2009, 182 (5): 3223-3232. 10.4049/jimmunol.0802064View ArticlePubMedGoogle Scholar
- Yang R, Tan X, Thomas AM, Steppacher R, Qureshi N, Morrison DC, Van Way CW: Alanine-glutamine dipeptide (AGD) inhibits expression of inflammation-related genes in hemorrhagic shock. JPEN J Parenter Enteral Nutr. 2007, 31 (1): 32-36. 10.1177/014860710703100132View ArticlePubMedGoogle Scholar
- Sharma M, Ganguly NK, Chaturvedi G, Thingnam SK, Majumdar S, Suri RK: Release of pro-inflammatory mediators during myocardial ischemia/reperfusion in coronary artery bypass graft surgery. Mol Cell Biochem. 2003, 247 (1-2): 23-30.View ArticlePubMedGoogle Scholar
- Mollen KP, Levy RM, Prince JM, Hoffman RA, Scott MJ, Kaczorowski DJ, Vallabhaneni R, Vodovotz Y, Billiar TR: Systemic inflammation and end organ damage following trauma involves functional TLR4 signaling in both bone marrow-derived cells and parenchymal cells. J Leukoc Biol. 2008, 83 (1): 80-88.View ArticlePubMedGoogle Scholar
- Prince JM, Levy RM, Yang R, Mollen KP, Fink MP, Vodovotz Y, Billiar TR: Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock. J Am Coll Surg. 2006, 202 (3): 407-417. 10.1016/j.jamcollsurg.2005.11.021View ArticlePubMedGoogle Scholar
- Singer P, Shapiro H, Theilla M, Anbar R, Singer J, Cohen J: Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med. 2008, 34 (9): 1580-1592. 10.1007/s00134-008-1142-4View ArticlePubMedGoogle Scholar
- Breil I, Koch T, Heller A, Schlotzer E, Grunert A, van Ackern K, Neuhof H: Alteration of n-3 fatty acid composition in lung tissue after short-term infusion of fish oil emulsion attenuates inflammatory vascular reaction. Crit Care Med. 1996, 24 (11): 1893-1902. 10.1097/00003246-199611000-00021View ArticlePubMedGoogle Scholar
- Koch T, Duncker HP, Klein A, Schlotzer E, Peskar BM, van Ackern K, Neuhof H: Modulation of pulmonary vascular resistance and edema formation by short-term infusion of a 10% fish oil emulsion. Infusionsther Transfusionsmed. 1993, 20 (6): 291-300.PubMedGoogle Scholar
- Carpentier YA, Peltier S, Portois L, Sener A, Malaisse WJ: Rapid lipid enrichment in omega3 fatty acids: plasma data. Int J Mol Med. 2008, 21 (3): 355-365.PubMedGoogle Scholar
- Calder PC: Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients. Braz J Med Biol Res. 2003, 36 (4): 433-446. 10.1590/S0100-879X2003000400004View ArticlePubMedGoogle Scholar
- Calder PC: Dietary modification of inflammation with lipids. Proc Nutr Soc. 2002, 61 (3): 345-358. 10.1079/PNS2002166View ArticlePubMedGoogle Scholar
- Ertel W, Morrison MH, Ayala A, Chaudry IH: Modulation of macrophage membrane phospholipids by n-3 polyunsaturated fatty acids increases interleukin 1 release and prevents suppression of cellular immunity following hemorrhagic shock. Arch Surg. 1993, 128 (1): 15-20. discussion 20-11, 10.1001/archsurg.1993.01420130019004View ArticlePubMedGoogle Scholar
- Fink MP: Gastrointestinal mucosal injury in experimental models of shock, trauma, and sepsis. Crit Care Med. 1991, 19 (5): 627-641. 10.1097/00003246-199105000-00009View ArticlePubMedGoogle Scholar
- Pittet YK, Berger MM, Pluess TT, Voirol P, Revelly JP, Tappy L, Chiolero RL: Blunting the response to endotoxin in healthy subjects: effects of various doses of intravenous fish oil. Intensive Care Med. 2010, 36 (2): 289-295. 10.1007/s00134-009-1689-8View ArticlePubMedGoogle Scholar
- Calder PC, Bond JA, Harvey DJ, Gordon S, Newsholme EA: Uptake and incorporation of saturated and unsaturated fatty acids into macrophage lipids and their effect upon macrophage adhesion and phagocytosis. Biochem J. 1990, 269 (3): 807-814.PubMed CentralView ArticlePubMedGoogle Scholar
- Mayer K, Meyer S, Reinholz-Muhly M, Maus U, Merfels M, Lohmeyer J, Grimminger F, Seeger W: Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans. J Immunol. 2003, 171 (9): 4837-4843.View ArticlePubMedGoogle Scholar
- Oz HS, Chen TS, Neuman M: Nutrition intervention: a strategy against systemic inflammatory syndrome. JPEN J Parenter Enteral Nutr. 2009, 33 (4): 380-389. 10.1177/0148607108327194PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.